 0 Table of Contents |
  1 Home |
  2 Background |
  3 Change Notes |
  4 Downloads |
  5 Specification |
  6 Artifacts Summary |
   6.1 Central Cancer Registry Reporting Pathology EHR Capability Statement |
   6.2 Pathology Laboratory Information System |
   6.3 IHE SDC/eCP on FHIR Observation |
   6.4 US Pathology Bundle |
   6.5 US Pathology Composition Laboratory Report |
   6.6 US Pathology Diagnostic Report |
   6.7 US Pathology Observation |
   6.8 US Pathology Related Practitioner Role |
   6.9 US Pathology Service Request |
   6.10 US Pathology Specimen |
   6.11 Document DiagnosticReport Reference |
   6.12 CAP eCC Answer Codes |
   6.13 CAP eCC Form Codes |
   6.14 CAP eCC Question Codes |
   6.15 CAP eCC Section Codes |
   6.16 US Pathology Provider Types |
   6.17 CAP eCC CodeSystem |
   6.18 US Pathology Code System |
   6.19 Additional Dimension Observation |
   6.20 Additional Findings Observation example |
   6.21 Additional Findings Section |
   6.22 Adrenalectomy Procedure Observation example |
   6.23 Breast Biomarker Testing Performed on Previous Biopsy |
   6.24 Breast Specimen Example |
   6.25 Breast Tissue Excision Observation Example |
   6.26 Case Summary Section |
   6.27 Clinical History Observation example |
   6.28 Clinical Section |
   6.29 Closest Margin(s) to Invasive Carcinoma example |
   6.30 Comments Section |
   6.31 Composition - Examination of Resection Specimens from Patients with Invasive Carcinoma of the Breast |
   6.32 Distant Metastasis Observation example |
   6.33 Distant Metastasis Section |
   6.34 Ductal Carcinoma In Situ Observation Example |
   6.35 Estrogen Receptor (ER) Status |
   6.36 FIGO Stage Section |
   6.37 Functional Status (Notes A,B) (select all that apply) example |
   6.38 General Tumor Site Observation |
   6.39 Glandular/Tubular Differentiation Observation Example |
   6.40 HER2 (by immunohistochemistry) |
   6.41 HER2 Observation Example |
   6.42 Histologic Grade Observation Example |
   6.43 Histologic Type Observation example |
   6.44 Lymph Nodes Section |
   6.45 Margin Distance from Invasive Carcinoma to Closest Margin example |
   6.46 Margin Status for Invasive Carcinoma Observation example |
   6.47 Margins Section |
   6.48 Mitotic Rate Observation Example |
   6.49 Next-of-Kin RelatedPerson example |
   6.50 Nuclear Pleomorphism Observation Example |
   6.51 Number of Sentinel Nodes Examined |
   6.52 Observation for Clock Position General |
   6.53 Oncologist Practitioner example |
   6.54 Oncologist PractitionerRole example |
   6.55 Overall Grade Observation Example |
   6.56 Pathologist Practitioner example |
   6.57 Pathology specimen collection procedure example |
   6.58 Patient Age Group Observation example |
   6.59 Patient example |
   6.60 Primary Tumor Observation example |
   6.61 Principal Pathology Lab example |
   6.62 PTNM Classification Observation example |
   6.63 pTNM Classification Section |
   6.64 Redwood Women's Center, P.C. example |
   6.65 Regional Lymph Nodes Observation example |
   6.66 Regional Lymph Nodes PT Category Observation example |
   6.67 Regional Lymph Nodes Section |
   6.68 Regional Lymph Nodes Status Observation example |
   6.69 Service Request - Cancer Pathology example |
   6.70 Special Studies Estrogen Receptor |
   6.71 Special Studies Section |
   6.72 Specific Clock Position Observation (8 o'clock) |
   6.73 Specimen Laterality Observation Example |
   6.74 Specimen Section |
   6.75 Surgeon Practitioner example |
   6.76 Surgeon PractitionerRole example |
   6.77 TNM Descriptors Observation example |
   6.78 Total Number of Lymph Nodes Examined (sentinel and non-sentinel) example |
   6.79 Tumor Extension Observation example |
   6.80 Tumor Extent Observation Example |
   6.81 Tumor Focality Observation Example |
   6.82 Tumor Invasion Observation example |
   6.83 Tumor Section |
   6.84 Tumor Size Observation |
   6.85 Tumor Weight Observation example |
   6.86 US Pathologist PractitionerRole example |
   6.87 US Pathology Breast Invasive Carcinoma DiagnosticReport example |
   6.88 US Pathology Encounter Specimen Collection example |
   6.89 US Pathology Exchange bundle example |